RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-1094
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_1008200; Gene model (P.falciparum): PF3D7_1436600; Gene product: cGMP-dependent protein kinase (PKG)
Details mutation: The P. berghei pkg gene replaced by the P. falciparum pkg gene
Transgene
Transgene not Plasmodium: GFP (gfp-mu3)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Fertilization and ookinete; Oocyst; Sporozoite;
Last modified: 14 June 2014, 18:40
  *RMgm-1094
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 24805991
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherTewari R; Baker DA
Name Group/DepartmentDepartment of Pathogen Molecular Biology
Name InstituteFaculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine
CityLondon
CountryUK
Name of the mutant parasite
RMgm numberRMgm-1094
Principal namePb(pfpkg)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNormal numbers of gametocytes. Normal rates of exflagellation. Strongly reduced ookinete formation (ookinete conversion rates of wild typpe 63% and of the mutant 10%)
OocystNormal numbers of gametocytes. Normal rates of exflagellation. Strongly reduced ookinete formation (ookinete conversion rates of wild typpe 63% and of the mutant 10%. Reduced oocyst production.
SporozoiteNormal numbers of gametocytes. Normal rates of exflagellation. Strongly reduced ookinete formation (ookinete conversion rates of wild typpe 63% and of the mutant 10%. Reduced oocyst production. No sporozoites in salivary glands.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
In the mutants the endogenous pkg gene has been replaced by the orthologous pkg gene of P. falciparum. In addition the mutant expresses GFP under the constitutive eef1a promoter

Protein (function)
Cyclic GMP-dependent protein kinases (PKGs) are the major mediators of the cGMP signal transduction pathway and regulate a variety of physiological effects. PKG is is a serinethreonine kinase that transfers the γ-phosphate of ATP, in a cGMP-dependent manner, to a variety of substrate proteins.

Evidence has been presented that in Plasmodium species that activation of PKG is critically required to regulate cytosolic Ca2+ levels. PKG emerges as a universal regulator that controls ookinete gliding, gametocyte activation, and schizont rupture.

Phenotype
Phenotype analyses indicate that PfPKG can functionally complement PbPKG in asexual blood stages of Pbpfpkg parasites, as well as in gametocyte development and male gametogenesis, replacement of the endogenous gene with PfPKG leads to a decreased conversion into ookinete stages, reduced oocyst production and no detectable sporozoites causing a block of parasite transmission in the mosquito.

Additional information
The mutant can be useful for in vivo screening future generations of cyclic GMPdependent protein kinase inhibitors and allowing to overcome any species-specific differences in the enzyme primary sequence that would influence in vivo efficacy in the rodent model.

Other mutants
See this link


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1008200
Gene Model P. falciparum ortholog PF3D7_1436600
Gene productcGMP-dependent protein kinase
Gene product: Alternative namePKG
Details of the genetic modification
Short description of the mutationThe P. berghei pkg gene replaced by the P. falciparum pkg gene
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationpfpkg coding region was amplified from cDNA using the primer pair SacIIPfPKG 5'-
CCCCCCGCGGATGGAAGAAGATGATAATCTAAAAAAAGGG-3' and BglIIPfPKG 5-CCCCAGATCTTTAAAAATCTATGTCCCAGTTGTCTTC-3'
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 15'-CCCCGGGCCCCCCCAATTGACGCCATTTCAACTGAG-3'
Additional information primer 1a 979 bp fragment upstream of the pbpkg ATG start codon was amplified using the primers ApaIPKG
Sequence Primer 25'-CCCCCCGCGGTTTTCTTATCTTCCAATCTCGTTAAC-3'
Additional information primer 2a 979 bp fragment upstream of the pbpkg ATG start codon was amplified using the primers SacIIPKG
Sequence Primer 35'-CCCCAGATCTTTGAGGAAAGTGATAAAAACAGAG-3'
Additional information primer 3A 438 bp spacer region corresponding to part of the pbpkg 3'UTR downstream of the stop codon was cloned between BglII and PstI restriction sites
Sequence Primer 45'-CCCCCTGCAGCATATATACATGTGTGCATTTAC-3'
Additional information primer 4A 438 bp spacer region corresponding to part of the pbpkg 3'UTR downstream of the stop codon was cloned between BglII and PstI restriction sites
Sequence Primer 55'-CCCCCTCGAGTTGAGGAAAGTGATAAAAACAGAG-3'
Additional information primer 5a 1100 bp region of the 3'UTR was cloned into XhoI and NotI restriction sites using primers XhoIPKG
Sequence Primer 65'-CCCCGCGGCCGCCTGTCAGATAAAGAAATTTCGTTAAAAC-3'
Additional information primer 6a 1100 bp region of the 3'UTR was cloned into XhoI and NotI restriction sites using primers Not1PKG

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mu3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4